Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Soft-Tissue Sarcomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00413192
What this trial is testing

E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eisai Inc. 128
Early research (Phase 1)Not Yet RecruitingNCT05361954
What this trial is testing

Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors

Who this might be right for
CancerCancer of PancreasSarcoma+2 more
Sorrento Therapeutics, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT02448537
What this trial is testing

A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas

Who this might be right for
Metastatic Sarcoma
Massachusetts General Hospital 42
Testing effectiveness (Phase 2)Study completedNCT00217607
What this trial is testing

Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery

Who this might be right for
Sarcoma
UNICANCER 30
Testing effectiveness (Phase 2)Study completedNCT02249702
What this trial is testing

Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Mario Negri Institute for Pharmacological Research 168
Testing effectiveness (Phase 2)Study completedNCT00053794
What this trial is testing

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerSarcoma
NCIC Clinical Trials Group 17
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Looking for participantsNCT04370587
What this trial is testing

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorMelanomaHNSCC+3 more
ImmVira Pharma Co. Ltd 30
Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Not applicableUnknownNCT04628806
What this trial is testing

Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells

Who this might be right for
Melanoma Stage IVSarcomaSquamous Cell Carcinoma+3 more
Charite University, Berlin, Germany 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03282344
What this trial is testing

NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Who this might be right for
SARCOMA
Memorial Sloan Kettering Cancer Center 88
Testing effectiveness (Phase 2)Ended earlyNCT04996004
What this trial is testing

Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Pfizer 76
Not applicableActive Not RecruitingNCT01737619
What this trial is testing

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Mixed AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more
M.D. Anderson Cancer Center 101
Early research (Phase 1)Ended earlyNCT04901806
What this trial is testing

Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

Who this might be right for
Solid Tumor, AdultBrain Tumor, PrimaryDesmoplastic Small Round Cell Tumor
Pyramid Biosciences 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT05886634
What this trial is testing

Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

Who this might be right for
Dedifferentiated LiposarcomaSoft Tissue SarcomaSarcoma,Soft Tissue+4 more
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT06683846
What this trial is testing

Ivonescimab in the Treatment of Multiple Advanced Tumors

Who this might be right for
Pheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more
Fudan University 400
Early research (Phase 1)Ended earlyNCT03670069
What this trial is testing

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Who this might be right for
Metastatic LeiomyosarcomaMetastatic Synovial SarcomaMetastatic Undifferentiated Pleomorphic Sarcoma+15 more
Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00484341
What this trial is testing

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.

Who this might be right for
Metastatic Adult Soft Tissue Sarcoma
AGC Biologics S.p.A. 69
Next Page